Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Cyclacel Pharma (CYCC) Tops Q2 EPS by 8c

August 10, 2022 4:29 PM EDT

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.46), $0.08 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

... More